Company
CanadaApotex, Inc. BioClinical Development Clinical Operations Department, North York, Canada – FDA Inspections
Inspection records and compliance data for Apotex, Inc. BioClinical Development Clinical Operations Department in North York. 2 FDA inspections on record, 1 Form 483, last inspected February 17, 2017.
Company Profile
This profile covers Apotex, Inc. BioClinical Development Clinical Operations Department based in North York, Canada.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 2
- Form 483s
- 1
- Warning letters
- 0
First inspected January 13, 2017. Last inspected February 17, 2017.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| February 17, 2017 | Not classified | Human Drugs | 1005519 |
| January 13, 2017 | Not classified | Human Drugs | 1002932 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Apotex, Inc. BioClinical Development Clinical Operations Department
FEI Number
3003673812
Address
465 Garyray Dr, North York, Canada
Country
Canada
ID: f69d2ce8-d899-45bb-93f7-a75b3e6a8702